Compare BLND & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLND | PLSE |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | 419 | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.5M | 3.6B |
| IPO Year | 2021 | 2015 |
| Metric | BLND | PLSE |
|---|---|---|
| Price | $1.12 | $51.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $4.13 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 1.8M | 612.2K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.33 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $123,585,000.00 | N/A |
| Revenue This Year | $12.62 | $840.00 |
| Revenue Next Year | $14.00 | $287.54 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.06 | $12.56 |
| 52 Week High | $3.86 | $58.90 |
| Indicator | BLND | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 30.83 | 54.39 |
| Support Level | N/A | $49.01 |
| Resistance Level | $1.60 | $58.90 |
| Average True Range (ATR) | 0.07 | 4.59 |
| MACD | -0.03 | -0.70 |
| Stochastic Oscillator | 11.68 | 35.18 |
Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segment is Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience. The key revenue for the company is generated from the Blend Platform segment. Company has it's assets in united states, India and Mexico regions.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.